Treeway Competitors and Similar CompaniesClear all

Treeway's competitors and similar companies include Cardiorentis, San Rocco Therapeutics and Temisis Therapeutics.
Treeway
Treeway
Treeway is a clinical-stage biotechnology company.
Cardiorentis
Cardiorentis
Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.
San Rocco Therapeutics
San Rocco Therapeutics
San Rocco Therapeutics (formerly known as Errant Gene Therapeutics (EGT) is a company developing treatments for life-threatening diseases recognized as rare disorders or orphan diseases.
Temisis Therapeutics
Temisis Therapeutics
Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.
Founding Date
Founding Date
2012
Founding Date
N/A
Founding Date
2003
Founding Date
N/A
Type
Type
Private
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
Tilburg, NL HQ
Locations
Zug, CH HQ
Freienbach, CH
Locations
Chicago, US HQ
Roma, IT
New York, US
Los Angeles, US
Locations
Vandœuvre-lès-Nancy, FR HQ
Employees
Employees
12
Employees
N/A
Employees
4
Employees
2

Funding

Total funding raised
Total funding raised
$ 55.8k
Total funding raised
$ 118.5m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Cardiorentis
HQ
Zug, CH

Cardiorentis is a biopharmaceutical company, developing drug therapies for the treatment of acute heart failure and related cardiovascular diseases.

View company
San Rocco Therapeutics
HQ
Chicago, US
Employees
4

San Rocco Therapeutics (formerly known as Errant Gene Therapeutics (EGT) is a company developing treatments for life-threatening diseases recognized as rare disorders or orphan diseases.

View company
Temisis Therapeutics
HQ
Vandœuvre-lès-Nancy, FR
Employees
2

Temisis Therapeutics is a therapeutic company focusing on the development of small-molecule assets for the treatment of unmet needs in pathologies possessing an inflammatory component.

View company